Management of atopic dermatitis (AD) has evolved from simple symptom relief to a multi-tiered approach focused on barrier repair, inflammation control, and targeted systemic therapies.
: The first-line therapy for flares. They range from low to ultra-high potency, with selection based on patient age and affected body site (e.g., low-potency for the face). ATOPIC DERMATITIS THERAPY
: Tacrolimus (ointment) and pimecrolimus (cream) are steroid-sparing alternatives particularly useful for sensitive areas like the face or skin folds. Newer Topicals : Crisaborole : A PDE-4 inhibitor for mild-to-moderate AD. Management of atopic dermatitis (AD) has evolved from
: These are essential for all patients, even during remission. even during remission.